Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip [Reuters]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Reuters
The supplier of laboratory apparatus and instruments for drug manufacturers and biotech companies continues to see adjusted revenue growth for the full-year between 1% and 2.5% on a currency-neutral basis. Large rival Thermo Fisher Scientific slightly bumped up its annual profit forecast in April while Waters Corp left its outlook for the year unchanged as it remains cautious about a recovery in its key markets. Subdued spending in the biotech sector as well as sluggish demand in the key China market has hit Bio-Rad's life sciences segment sales, offset by an increase in demand for its clinical diagnostics products. The Hercules, California-based company continues to be cautiously optimistic about a gradual recovery in the biopharma market in the second half of the year. Sales from its life sciences unit, which makes products for biotech, pharmaceutical and food testing clients, fell 25.3% to $241.7 million. On an adjusted basis, Bio-Rad recorded a per-share profit of $2.29
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Galapagos enters deal to boost decentralised CAR-T therapy production [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array [Yahoo! Finance]Yahoo! Finance
- Cancer Biomarkers Market is Expected to Reach $42.0 billion | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific Introduces Array-based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions [Yahoo! Finance]Yahoo! Finance
- Medidata expands clinical trial software partnership with Worldwide Clinical Trials [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 4/24/24 - Beat
TMO
Sec Filings
- 5/15/24 - Form 4
- 5/15/24 - Form 4
- 5/14/24 - Form 4
- TMO's page on the SEC website